Coherus Oncology, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Coherus Oncology, Inc. (CHRS) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $280.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-03-09
- Coherus Oncology, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $280.00K.
- Coherus Oncology, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $42.00K.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $280.00K 10-K · filed 2026-03-09 |
| 2023-12-31 | $286.00K 8-K · filed 2025-11-13 |
| 2022-12-31 | $42.00K 10-K · filed 2025-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |